CalciMedica Inc reports results for the quarter ended September 30 - Earnings Summary

Calcimedica

13/11/2024 14:15

* CalciMedica Inc  CALC.OQ  reported a quarterly adjusted
loss
of 50 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -82 cents.  The mean expectation of
three analysts for the quarter was for a loss of 50 cents per
share. Wall Street expected results to range from -64 cents
to -41 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * CalciMedica Inc's reported EPS for the quarter was a loss
of 50
cents​.
    * The company reported a quarterly loss of $5.62 million.
    * CalciMedica Inc shares had fallen by 21.2% this
quarter and
gained 22.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CalciMedica Inc
is 16.00 
This summary was machine generated from LSEG data November 13 at
02:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.50          -0.50          Met
 Jun. 30 2024      -0.53          -0.36          Beat
 Mar. 31 2024      -0.67          0.01           Beat
 Dec. 31 2023      -0.87          -0.23          Beat